Compound Monograph
Lactucin
Lactucin is the principal bitter guaianolide of lactucarium — the dried latex of wild lettuce and chicory once sold as "lettuce opium." It is not an opioid and has no chemical relationship to one. The isolated molecule is genuinely sedative and analgesic in mice and interacts with the GABA-A benzodiazepine site, but no clinical trial has ever tested it.
Sources · 8
Where Does It Come From?
Lactucin is a naturally occurring sesquiterpene lactone (guaianolide, lactucin type), found in Wild lettuce, Garden lettuce, Chicory and 5 other sources. It is well tolerated orally (low toxicity).
Principal source Wild Lettuce Lactuca virosa Herb monograph →
Source Dandelion Taraxacum officinale Herb monograph → Concentration
Content by Source
Reported concentrations across the plants that contain lactucin — the bar marks the typical level, the line shows the reported range.
Literature figures for varying plant parts and preparations. Read them as a comparative guide, not exact assays.
Lactucin at a Glance
Lactucin is a guaianolide sesquiterpene lactone — the principal bitter molecule of lactucarium, the dried milky latex of wild lettuce (Lactuca virosa) and its relatives. It is a large part of why a bolted lettuce, an endive or a chicory root tastes bitter, and it is the compound that carries most of the pharmacological reputation of “lettuce opium” 1,
That reputation needs handling carefully, and it is handled up front. Lactucin is not an opioid, is not chemically related to one, and lactucarium contains no opiate alkaloids. The nickname is a 19th-century materia-medica accident, not a chemical description 19Reference 19ReviewLettuce (Lactuca sp.) as a medicinal plant in Polish publications of the 19th century — historical reviewView study →. What is real is a small, consistent preclinical signal: isolated lactucin is analgesic and sedative in mice at 15–30 mg/kg 1Reference 1AnimalAnalgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice — animal in vivoView study →, it displaces the benzodiazepine-site radioligand [³H]-flumazenil from GABA-A receptors 2Reference 2AnimalEffectiveness of the sleep enhancement by green romaine lettuce (Lactuca sativa) in a rodent model — animal in vivoView study →, and it is a potent anti-neuroinflammatory agent in cultured cells 6Reference 6In vitroGuaianolide sesquiterpene lactones from Cichorium glandulosum and their anti-neuroinflammation activities — in vitroView study →. Since 2020 the most active research has actually moved away from the nervous system entirely, toward the liver and metabolism 7,
Two structural facts govern everything below. First, the plant does not store free lactucin — it stores oxalate and sulfate conjugates in the latex, and the free molecule most chemistry has studied is largely liberated by wounding, drying and extraction 3Reference 3In vitroMetabolite profiling of sesquiterpene lactones from Lactuca species: major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives — in vitroView study →. Second, lactucin’s reactive α-methylene-γ-lactone group — the shared warhead of the sesquiterpene-lactone class — is hydrogenated by human gut bacteria before absorption, which is a serious problem for reading its in-vitro pharmacology onto a salad 4Reference 4Clinical trialHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteersView study →.
”Lettuce Opium”: Myth vs. Evidence
The claim that dried lettuce latex is a mild opium substitute is genuinely old and genuinely well documented — as a belief. Nineteenth-century Polish medical literature reviewed by Trojanowska records lactucarium as an intoxicant used as a sedative and analgesic, described as weaker than opium but free of its side-effects, with practitioners reporting that in some cases it worked better 19Reference 19ReviewLettuce (Lactuca sp.) as a medicinal plant in Polish publications of the 19th century — historical reviewView study →. That same historical review records the crucial epilogue: contemporary chemists set out to identify the substance responsible and failed 19Reference 19ReviewLettuce (Lactuca sp.) as a medicinal plant in Polish publications of the 19th century — historical reviewView study →. The reputation arrived first; the chemistry never caught up with it.
Here is the honest ledger.
What is myth. That lactucarium contains an opiate, acts on opioid receptors, or is pharmacologically a “natural opium.” None of these is true. There is no opiate alkaloid in Lactuca, and no opioid-receptor activity has been published for lactucin. The name is the entire basis of the claim.
What is untested. Essentially the whole traditional use. There is no controlled study of lactucarium, none of Lactuca virosa, and no clinical trial of lactucin. The two small human sleep trials that circulate in this literature used Lactuca sativa seed oil — a different plant part of a different species, with no meaningful sesquiterpene-lactone content — so they are not evidence for lactucin at all.
What is real, at the preclinical tier. Wesołowska and colleagues tested lactucin, lactucopicrin and 11β,13-dihydrolactucin side by side in mice and found all three analgesic in hot-plate and tail-flick tests at 15 and 30 mg/kg, comparable to ibuprofen at 30–60 mg/kg — and found lactucin and lactucopicrin, but not 11β,13-dihydrolactucin, sedative in the spontaneous-locomotor test 1Reference 1AnimalAnalgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice — animal in vivoView study →. That single 2006 paper is still the strongest direct support the traditional claim has, and it is a mouse study of purified compounds, not of lactucarium.
The consolation prize. Tradition was directionally right about the class — bitter guaianolides, not opiates, are what carry wild lettuce’s sedative and analgesic reputation. It was wrong about the mechanism, wrong about the comparison to opium, and it has never been checked in a person.
The Conjugate Problem: What the Plant Actually Stores
Most of the lactucin literature quietly assumes the molecule exists in the plant as drawn. It largely does not.
Sessa and colleagues profiled Lactuca latex directly and found that its major components are 15-oxalyl and 8-sulfate conjugates of lactucin, deoxylactucin and lactucopicrin — not the free lactones 3Reference 3In vitroMetabolite profiling of sesquiterpene lactones from Lactuca species: major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives — in vitroView study →. The oxalates are unstable and revert to the parent sesquiterpene lactone on hydrolysis; the sulfates are stable, and were the first sesquiterpene sulfates reported from any plant 3Reference 3In vitroMetabolite profiling of sesquiterpene lactones from Lactuca species: major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives — in vitroView study →. Chicory latex carries the oxalyl conjugates but, notably, lacks the 8-sulfates 3Reference 3In vitroMetabolite profiling of sesquiterpene lactones from Lactuca species: major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives — in vitroView study →. Conjugate proportions also shift with developmental stage 3Reference 3In vitroMetabolite profiling of sesquiterpene lactones from Lactuca species: major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives — in vitroView study →, and chicory work confirms the same picture — the guaianolides accumulate in taproot latex predominantly in oxalated forms 5Reference 5In vitroLactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.) — in vitroView study →.
Three consequences follow, and they shape everything that comes after:
- Free lactucin is substantially a preparation artifact. Wounding, drying and solvent extraction hydrolyse the labile oxalates. The lactucarium of the old materia medica, and the “lactucin content” of a modern extract assay, are both partly made by the process that measures them.
- Species and cultivar profiles are not interchangeable. Sesquiterpene-lactone profiles vary substantially between lettuce varieties and between Lactuca species 3Reference 3In vitroMetabolite profiling of sesquiterpene lactones from Lactuca species: major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives — in vitroView study →, and stem-chicory transcriptome and metabolite work shows the pathway is under real genetic and developmental control 38Reference 38In vitroInsights into the sesquiterpenoid pathway by metabolic profiling and de novo transcriptome assembly of stem-chicory (Cichorium intybus cultigroup “Catalogna”) — in vitroView study →. A figure from romaine lettuce does not transfer to L. virosa.
- The conjugates are themselves the story of lettuce bitterness. Sessa’s group explicitly proposed these constitutive lactones as the molecular basis of the bitter taste of lettuce and related species, and found no correlation with pathogen resistance 3Reference 3In vitroMetabolite profiling of sesquiterpene lactones from Lactuca species: major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives — in vitroView study → — which reframes lactucin as a taste compound with pharmacology attached rather than a defence toxin.
Lactucin-8-sulfate has its own entry as a distinct latex constituent for exactly this reason.
The Michael-Acceptor Warhead — and What the Gut Does to It
Lactucin does carry the exocyclic α-methylene-γ-lactone group. This is not an assumption: the existence of 11β,13-dihydrolactucin as a separately named, separately tested compound in the same 2006 study defines lactucin as the unreduced parent 1Reference 1AnimalAnalgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice — animal in vivoView study →, and gut-microbiota work recovers tetrahydrolactucin and hexahydrolactucin from lactucin through “double bond hydrogenations,” which requires the double bond to have been there 4Reference 4Clinical trialHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteersView study →.
That group is a Michael acceptor. It alkylates cysteine thiols, and it is the shared reason most sesquiterpene lactones inhibit NF-κB, engage Keap1/Nrf2, and show broad cytotoxicity across unrelated cell lines. This is a class property, not a lactucin property. When you read that lactucin suppresses NF-κB, downregulates BCL-2, or kills a cancer cell line at micromolar concentrations, the correct first hypothesis is thiol alkylation shared with parthenolide, costunolide and several hundred other lactones — which is also why such compounds are usually poorly selective. Class reactivity is labelled as class reactivity.
The genuinely lactucin-specific claims are narrower and worth separating out:
- Sedation. Lactucin and lactucopicrin are sedative in mice; 11β,13-dihydrolactucin — the same molecule with the warhead reduced — is analgesic but not sedative 1Reference 1AnimalAnalgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice — animal in vivoView study →. That dissociation is a real structure–activity result, and it points the wrong way for a pure thiol-alkylation story: the reduced compound keeps analgesia and loses sedation.
- The GABA-A interaction, which is a binding-site phenomenon rather than an alkylation one 2Reference 2AnimalEffectiveness of the sleep enhancement by green romaine lettuce (Lactuca sativa) in a rodent model — animal in vivoView study →.
- Potency at low micromolar in a neuroinflammation assay (IC₅₀ 1.82 µM), where lactucin was one of only four actives among twenty guaianolides tested — meaning most of the class, warhead and all, was inactive in that assay 6Reference 6In vitroGuaianolide sesquiterpene lactones from Cichorium glandulosum and their anti-neuroinflammation activities — in vitroView study →.
And the sting in the tail: the human gut microbiota hydrogenates the α-methylene double bond before absorption 4Reference 4Clinical trialHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteersView study →. Whatever the warhead does in a dish, it is chemically disarmed on the way in.
What It's Used For
Lactucin sits entirely in the preclinical tier. The evidence has two distinct halves: an older, thinner neuropharmacology literature that carries the traditional reputation, and a much more active post-2020 body of hepatic and metabolic work — most of it in mice, all of it using the isolated molecule, and most of it converging on AMPK/SIRT1 signalling rather than on anything to do with sedation.
Support is an experimental score I’m building — a composite weighted by study type (human > animal > in vitro > review) and study volume. It’s a beta: a fast way to rank strength of evidence at a glance, not a validated metric, and I’ll keep honing the formula over time. Each application name links down to its write-up.
This is the traditional core, and the one place where isolate data and plant data point the same way. Isolate: lactucin reduced spontaneous locomotor activity in mice — a sedation readout — as did lactucopicrin, while the reduced analogue 11β,13-dihydrolactucin did not 1Reference 1AnimalAnalgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice — animal in vivoView study →.
Mechanism: a green romaine Lactuca sativa extract inhibited [³H]-flumazenil binding concentration-dependently, and the paper reports the affinity of lactucin for the GABA-A–benzodiazepine receptor as 80.7%, against 55.9% for lactucopicrin 2Reference 2AnimalEffectiveness of the sleep enhancement by green romaine lettuce (Lactuca sativa) in a rodent model — animal in vivoView study →.
Read that number carefully — it is a percentage displacement of a radioligand in a binding assay, not a Kᵢ, and the reported abstract does not state the concentration at which it was measured; it establishes that lactucin engages the benzodiazepine site, not how tightly. Plant: the same study showed oral extract increased sleep duration, raised non-REM sleep, reversed caffeine-induced insomnia, and had its effect abolished by flumazenil 2Reference 2AnimalEffectiveness of the sleep enhancement by green romaine lettuce (Lactuca sativa) in a rodent model — animal in vivoView study → — the cleanest causal link in the file. Independent rodent work replicates GABA-A–mediated sleep promotion by lettuce extract 20,
Gap: Every sleep result at the plant level uses Lactuca sativa extracts, not L. virosa or lactucarium; the isolate contributed one locomotor endpoint and one binding percentage. No Kᵢ, no dose–response, no receptor-subtype work, no brain-exposure measurement, and no human study of lactucin.
The most substantive in vivo work on lactucin, and it is recent. In a mouse model, lactucin reversed established liver fibrosis, inhibiting TGF-β1/STAT3 signalling and shifting short-chain fatty acid metabolism 7Reference 7AnimalLactucin reverses liver fibrosis by inhibiting TGF-β1/STAT3 signaling pathway and regulating short-chain fatty acids metabolism — animal in vivoView study →.
The same group then showed the effect runs partly through the gut: lactucin alleviated fibrosis by regulating TLR4-MyD88-MAPK/NF-κB signalling via the intestinal flora 8Reference 8AnimalLactucin alleviates liver fibrosis by regulating the TLR4-MyD88-MAPK/NF-κB signaling pathway through intestinal flora — animal in vivoView study → — which fits the microbiota-metabolism data 4Reference 4Clinical trialHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteersView study → and is one of the few mechanistic stories here that accommodates poor absorption rather than ignoring it. Supporting cell work in free-fatty-acid–loaded HepG2 hepatocytes reports reduced lipid accumulation through AMPK-mediated autophagy and β-oxidation 14Reference 14In vitroLactucin alleviates lipid accumulation via AMPK-mediated autophagy and fatty acid β-oxidation in FFA-induced HepG2 cells — in vitroView study →, through SIRT1/PGC-1α–linked mitochondrial homeostasis 13Reference 13In vitroLactucin ameliorates FFA-induced steatosis in HepG2 cells by modulating mitochondrial homeostasis through the SIRT1/PGC-1α signaling axis — in vitroView study →, and alongside lactucopicrin through general lipid-metabolism modulation 12Reference 12In vitroLactucin & lactucopicrin ameliorates FFA-induced steatosis in HepG2 cells via modulating lipid metabolism — in vitroView study →.
All isolate; no plant preparation and no human data.
Gap: Two fibrosis papers from an overlapping author group, with no independent replication and no cross-lab dose–response; the steatosis findings are a cell model of a disease defined by whole-organism physiology. Nothing connects these doses to dietary or lactucarium exposure.
One study carries this entirely. Wesołowska and colleagues tested lactucin, lactucopicrin and 11β,13-dihydrolactucin — named as the characteristic bitter lactones of Lactuca virosa and Cichorium intybus — in mice, and found analgesia at 15 and 30 mg/kg in the hot-plate test comparable to ibuprofen at 30 mg/kg, and at 30 mg/kg in the tail-flick test comparable to ibuprofen at 60 mg/kg, with lactucopicrin the most potent of the three 1Reference 1AnimalAnalgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice — animal in vivoView study →.
Both are thermal-nociception assays with a substantial central component. This is non-opioid antinociception; nothing in the paper or elsewhere implicates opioid receptors, and the “lettuce opium” name is not evidence of a mechanism. Isolated compounds only — no wild-lettuce preparation has been tested for analgesia in an animal.
Gap: A single 2006 paper, twenty years old and never independently replicated for lactucin. No mechanism was identified, no antagonist study was run to name a receptor, there is no dose–response beyond two points, and there is no human analgesia data of any kind.
A coherent post-2020 cluster around AMPK/SIRT1. In vivo: lactucin and lactucopicrin ameliorated obesity in high-fat-diet mice by promoting white adipose tissue browning through AMPK/SIRT1/PGC-1α 9Reference 9AnimalLactucin and lactucopicrin ameliorate obesity in high-fat diet fed mice by promoting white adipose tissue browning through activation of the AMPK/SIRT1/PGC-1α pathway — animal in vivoView study → — the one whole-animal result in this group. In vitro: lactucin inhibited adipogenesis by downregulating JAK2/STAT3 signalling and blocking mitotic clonal expansion in preadipocytes 10Reference 10In vitroA potential nutraceutical candidate lactucin inhibits adipogenesis through downregulation of JAK2/STAT3 signaling pathway-mediated mitotic clonal expansion — in vitroView study →, and enhanced glucose uptake and glycolysis in C2C12 myotubes via AMPK 11Reference 11In vitroLactucin enhances glucose uptake and glycolysis in C2C12 myotubes by activating AMPK signaling pathway — in vitroView study →.
The recurring AMPK/SIRT1 axis links this cluster to the hepatic steatosis findings above 13,
Gap: One animal study against several cell studies; no comparison against an established AMPK activator; no pharmacokinetics to show the effective concentrations are reachable; and no human metabolic endpoint. Isolate only — nobody has fed animals a bitter-lettuce or chicory preparation and measured browning.
Lactucin is a genuinely potent anti-neuroinflammatory agent in cell culture. In a phytochemical survey of Cichorium glandulosum that isolated eight new plus twelve known guaianolides, lactucin was one of only four compounds showing strong activity, with an IC₅₀ of 1.82 ± 0.27 µM 6Reference 6In vitroGuaianolide sesquiterpene lactones from Cichorium glandulosum and their anti-neuroinflammation activities — in vitroView study →.
The comparison matters more than the number: sixteen of the twenty guaianolides tested — most carrying the same α-methylene-γ-lactone — were not potent, which argues that this is not simple thiol-alkylation cytotoxicity masquerading as an anti-inflammatory readout. Note that the mechanistic follow-up in that paper (NF-κB and MAPK pathways) was performed on a different compound, not on lactucin 6Reference 6In vitroGuaianolide sesquiterpene lactones from Cichorium glandulosum and their anti-neuroinflammation activities — in vitroView study →.
Related work on the class in inflamed macrophages and endothelium is dominated by lactucopicrin rather than lactucin 34Reference 34AnimalNatural lactucopicrin alleviates importin-α3-mediated NF-κB activation in inflamed endothelial cells and improves sepsis in mice — animal in vivoView study →.
Gap: One screen, one endpoint, no mechanism established for lactucin specifically, no animal neuroinflammation model, and no blood–brain-barrier or brain-exposure data. A 1.8 µM IC₅₀ means little for a molecule whose plasma concentration after any realistic exposure is unknown.
Real but generic. Lactucin inhibited growth and induced apoptosis in gastric cancer cells by targeting MAPK signalling, with confirmation in a mouse xenograft 15Reference 15AnimalLactucin inhibits growth and induces apoptosis in gastric cancer cells by targeting MAPK signaling — animal in vivo (xenograft)View study →; a separate group reported antiproliferative activity via MAPK and central-carbon-metabolism downregulation 16Reference 16In vitroLactucin, a bitter sesquiterpene from Cichorium intybus, inhibits cancer cell proliferation by downregulating the MAPK and central carbon metabolism pathway — in vitroView study →; and in renal Caki-1 cells it induced apoptosis through ROS-mediated BCL-2 and CFLAR(L) downregulation 17Reference 17In vitroLactucin induces apoptosis through reactive oxygen species-mediated BCL-2 and CFLAR(L) downregulation in Caki-1 cells — in vitroView study →.
A bacterial-derived analogue, 3,4-dihydro-lactucin from Microbispora rosea, shows similar apoptotic potential 35Reference 35In vitroApoptotic potential and molecular docking of 3,4-dihydro-lactucin, a compound with anticancer properties derived from Microbispora rosea AL22 — in vitroView study →.
Read all of this against the class caveat above: ROS induction, BCL-2 downregulation and MAPK/NF-κB suppression are the standard fingerprint of an α-methylene-γ-lactone Michael acceptor and are reported for most of the class. Nothing here yet distinguishes lactucin from its structural relatives, and nothing addresses selectivity for tumour over normal tissue.
Gap: One cell line per cancer type, one xenograft, no selectivity index against non-malignant cells, no comparison with a standard cytotoxic, and no evidence that any dietary or herbal exposure approaches the concentrations used. This is exploratory pharmacology, not a use.
The thinnest signal. Screening of Cichorium intybus root constituents against the HB3 clone of Plasmodium falciparum — prompted by an Afghan folk report of chicory root as a light-sensitive malaria remedy — identified lactucin and lactucopicrin as the active molecules in vitro 18Reference 18In vitroAntimalarial activity of lactucin and lactucopicrin: sesquiterpene lactones isolated from Cichorium intybus L. — in vitroView study →. The light-sensitivity note is not incidental: lactucin is documented to undergo photochemical transformation 33Reference 33Studies on the photochemical transformation of lactucin — laboratory studyView study →, which complicates both the traditional preparation and any therapeutic reading.
Gap: A single in-vitro assay of isolated compounds from a different genus to wild lettuce, with no animal model, no potency benchmark against chloroquine or artemisinin, no resistance-strain data, and no relevance to how either plant is actually used.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| GABA-A benzodiazepine site (80.7% [³H]-flumazenil displacement; effect flumazenil-reversible in vivo) | positive modulation → sedation, longer sleep | sedative & sleep support |
| Adenosine A1 receptor + GABA-A subunit upregulation (plant extract) | prolonged sleep duration | sedative & sleep support |
| Unidentified non-opioid antinociceptive target | thermal analgesia at 15–30 mg/kg in mice | analgesia |
| TGF-β1/STAT3; TLR4-MyD88-MAPK/NF-κB via intestinal flora | reversal of established hepatic fibrosis | liver protection |
| AMPK / SIRT1 / PGC-1α | adipose browning, β-oxidation, mitochondrial homeostasis | metabolic effects & hepatic steatosis |
| JAK2/STAT3 → mitotic clonal expansion | inhibited adipogenesis | adiposity |
| α-methylene-γ-lactone thiol alkylation (class property) | NF-κB/MAPK suppression, ROS, BCL-2 ↓, broad cytotoxicity | anticancergeneral anti-inflammatory |
| Acetylcholinesterase (class context; lactucopicrin IC₅₀ ≈ 150 µM, 8-deoxylactucin ≈ 308 µM) | weak enzyme inhibition — lactucin is not the active member here | cognition claims made for the plant |
The last row is included deliberately. The acetylcholinesterase story that circulates for chicory and wild lettuce belongs to lactucopicrin and 8-deoxylactucin, not to lactucin — and even for them the inhibitory concentrations are high 23,
Pharmacokinetics
This is the most important section on the page and the one that constrains everything above.
Absorption and microbial transformation. García and colleagues performed the first study of human gut-microbiota metabolism of dietary sesquiterpene lactones, fermenting lactucin, lactucopicrin and romaine lettuce with faecal microbiota from independent donors 4Reference 4Clinical trialHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteersView study →. The dominant reactions were dehydroxylations and double-bond hydrogenations. Lactucin yielded tetrahydrolactucin and hexahydrolactucin — meaning the α-methylene group that drives the compound’s in-vitro reactivity is reduced away before absorption 4Reference 4Clinical trialHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteersView study →.
Human exposure is to metabolites, not to lactucin. In healthy volunteers who ate escarole salad, urine contained glucuronide and sulfate conjugates of dihydrolactucopicrin, tetrahydrolactucopicrin, dihydrolactucin and deoxylactucin — the reduced, phase-II–conjugated products — with large inter-subject variability tracking differences in gut microbiota composition 4Reference 4Clinical trialHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteersView study →. That variability is a pharmacological finding in its own right: the same salad delivers different metabolite profiles to different people.
Why this matters. The mouse studies dose lactucin directly at 15–30 mg/kg and above, bypassing or overwhelming this transformation; in-vitro work applies the intact molecule at micromolar concentrations. Neither reflects what reaches a person’s circulation from food. And the one structure–activity result available is not reassuring for the reduced forms: 11β,13-dihydrolactucin — the mono-reduced analogue — lost the sedative effect that lactucin retained 1Reference 1AnimalAnalgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice — animal in vivoView study →. If the gut performs that reduction and more, the sedative pharmacology of a dietary or oral herbal exposure is genuinely in doubt.
Not characterised for lactucin: oral bioavailability (no figure exists), plasma Cmax or half-life, protein binding, brain penetration, CYP interactions, or transporter substrate status. The molecule is also photolabile 18,
Clinical Trials
No registered clinical trial has tested lactucin, lactucarium, or Lactuca virosa in humans. The only human data touching this molecule at all is the escarole-salad metabolite study, which measured urinary metabolites and no clinical endpoint 4Reference 4Clinical trialHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteersView study →.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| 0 | 0 | 0 | ~20 |
Last checked: July 2026.
Isolate vs. Plant Studies
The split here is unusually clean, and unusually important, because the plant reputation and the molecule evidence come from different centuries and different species.
Isolate studies dominate the pharmacology. Every claim in the Pharmacology section above — sedation, analgesia, GABA-A binding, liver fibrosis, adipose browning, neuroinflammation, cytotoxicity, antimalarial activity — used purified lactucin 1,
Plant studies are almost all garden lettuce. The GABA-A/sleep replication set — flumazenil-reversible sleep promotion, adenosine A1 upregulation, caffeine-insomnia reversal — is Lactuca sativa leaf extract standardised on lactucin and lactucopicrin content 2,
Nothing tests the traditional article. There is no controlled study of lactucarium — the dried latex, the actual historical preparation — in any species. Given that the latex stores lactucin mainly as labile oxalate and stable sulfate conjugates 3Reference 3In vitroMetabolite profiling of sesquiterpene lactones from Lactuca species: major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives — in vitroView study →, lactucarium is not simply “lactucin, dried”; its composition depends on how it was collected and dried, and it has never been characterised pharmacologically.
Transferability verdict: weak in both directions. A mouse given 30 mg/kg purified lactucin is not a model of a person drinking wild-lettuce tea, and a romaine-lettuce extract’s sleep effect is not proof that any given lactucarium preparation does the same thing.
Prevalence in Nature
Lactucin is a latex compound of the Cichorieae tribe within Asteraceae — the lettuce/chicory/dandelion lineage — and it is functionally a taste and deterrence molecule rather than a trace metabolite.
Principal sources. Lactuca virosa and Lactuca sativa, in the milky latex of stems and leaves 1,
Concentrations. Reliable figures are scarce, and none exists for L. virosa itself. The best-anchored number is from a green romaine L. sativa extract, assayed at ~1,072 µg/g lactucin against ~199 µg/g lactucopicrin — a roughly 5:1 ratio favouring lactucin 2Reference 2AnimalEffectiveness of the sleep enhancement by green romaine lettuce (Lactuca sativa) in a rodent model — animal in vivoView study →. That figure is for an extract, not fresh tissue, and cannot be read as a plant content. Content varies substantially between lettuce varieties, between Lactuca species, and with developmental stage 3,
Beyond plants. A structural relative, 3,4-dihydro-lactucin, has been isolated from the actinomycete Microbispora rosea 35Reference 35In vitroApoptotic potential and molecular docking of 3,4-dihydro-lactucin, a compound with anticancer properties derived from Microbispora rosea AL22 — in vitroView study → — a reminder that guaianolide-type scaffolds are not exclusively higher-plant chemistry.
Its role in the plant. Lactucin sits at the end of the guaianolide branch of the sesquiterpene pathway: germacrene A synthase opens the route, and silencing those genes reduces guaianolide oxalate content in chicory 30Reference 30In vitroSilencing of germacrene A synthase genes reduces guaianolide oxalate content in Cichorium intybus L. — in vitroView study →; the final regiospecific hydroxylation of 8-deoxylactucin to lactucin is performed by the cytochrome P450 CYP71DD33, identified as chicory’s lactucin synthase by CRISPR/Cas9 knockout 5Reference 5In vitroLactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.) — in vitroView study →. That gene is expressed predominantly in the latex — meaning the late steps of the pathway happen in the very tissue that gets exuded when the plant is wounded 5Reference 5In vitroLactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.) — in vitroView study →. Functionally, the evidence points to taste and deterrence rather than pathogen defence: the constitutive lactones did not correlate with disease resistance, but were proposed as the molecular basis of lettuce bitterness 3Reference 3In vitroMetabolite profiling of sesquiterpene lactones from Lactuca species: major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives — in vitroView study →.
Why breeders care. That bitterness makes lactucin an explicit crop-improvement target, and the direction of travel is away from it. Knocking out CYP71DD33 in chicory almost completely eliminated lactucin and lactucopicrin and their oxalates, and correspondingly boosted 8-deoxylactucin and its derivatives — which the same group showed to have anti-inflammatory activity in an inflamed intestinal-mucosa model 5Reference 5In vitroLactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.) — in vitroView study →. Root chicory is being positioned as a crop from which different health-product fractions can be extracted 5Reference 5In vitroLactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.) — in vitroView study →, so the lactucin content of commercial chicory is now a deliberate breeding decision rather than a fixed botanical fact.
Discovery & Synthesis
First isolation. Lactucin belongs to the 19th-century lactucarium literature, when chemists were explicitly trying to find the substance responsible for lettuce latex’s sedative reputation — an effort the historical record describes as having failed to produce the expected results 19Reference 19ReviewLettuce (Lactuca sp.) as a medicinal plant in Polish publications of the 19th century — historical reviewView study →. A precise first-isolation attribution is not verified here and should be treated as open.
Modern preparative chemistry. The reproducible route dates to Schenck and co-workers, who published on the preparation of lactucin and lactucopicrin from Lactuca virosa plants in 1961, as part of a series on the enzymatic and non-enzymatic oxidation of therapeutically active plant substances 32Reference 32Research on the preparation of lactucin and lactucopicrin from Lactuca virosa plants (15: on the enzymatic and non-enzymatic oxidation of therapeutically active plant substances) — laboratory methodView study →. The same group established lactucin’s photochemical transformation in 1964 33Reference 33Studies on the photochemical transformation of lactucin — laboratory studyView study → — the earliest documentation of the light sensitivity that still complicates its handling. Structural work continued through NMR characterisation of lactucin-type guaianolides and their glycosides, and through the rearrangement chemistry that defines the lactucin skeleton 36,
Total synthesis. No total synthesis of lactucin is documented in the literature surveyed. Given the guaianolide’s stereochemical density and the reactive exocyclic methylene, that is unsurprising; the field has gone to plants instead.
Manufacture today. Supply is by extraction and semi-synthesis from chicory, not by synthesis. A three-step process published in 2023 isolates gram-scale quantities of bioactive sesquiterpene lactones from Cichorium intybus roots and derives semisynthetic chicory STL standards from them 31Reference 31A three-step process to isolate large quantities of bioactive sesquiterpene lactones from Cichorium intybus L. roots and semisynthesis of chicory STL standards — laboratory methodView study →; supercritical-fluid extraction of chicory STL fractions is used for the bioactivity work 5Reference 5In vitroLactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.) — in vitroView study →. Chicory root is the practical source for everything — reference standards, screening material, and the extract fractions being developed commercially. Metabolic engineering of the chicory pathway is an active alternative, running in both directions: silencing germacrene A synthase to reduce guaianolides 30Reference 30In vitroSilencing of germacrene A synthase genes reduces guaianolide oxalate content in Cichorium intybus L. — in vitroView study →, or knocking out lactucin synthase to redirect flux to 8-deoxylactucin 5Reference 5In vitroLactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.) — in vitroView study →.
Patents: not yet researched.
Toxicity & Safety
Direct toxicology on isolated lactucin is essentially absent. No LD₅₀, no repeat-dose study, no genotoxicity package, and no reproductive-toxicity dataset for the pure compound was located. The “low” rating here reflects dietary reassurance — lactucin is consumed routinely in lettuce, endive, escarole and chicory, and human volunteers eating escarole salad showed only ordinary metabolite excretion 4Reference 4Clinical trialHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteersView study → — not a characterised safety profile for the isolate. Do not read silence as safety.
The Plant Is Not as Benign as the Molecule
The overdose signal belongs to wild lettuce, not to lactucin, and it is real. A case report documents Lactuca virosa toxicity requiring hospital care 28Reference 28Case reportWild lettuce (Lactuca virosa) toxicity — case reportView study →, and a French report describes abuse of L. virosa 29Reference 29Case reportAbuse of Lactuca virosa — case reportView study →. Presentations in this literature involve agitation, dizziness, nausea and anticholinergic-type CNS effects. Nothing attributes these to lactucin specifically — lactucarium is a complex, unstandardised latex — but they are why concentrated wild-lettuce preparations warrant more caution than the “gentle sedative” framing suggests.
Sedation & Its Interactions
Lactucin’s sedative activity is benzodiazepine-site–linked 1,
Asteraceae Contact Dermatitis
Lettuce contact allergy is documented, mostly occupational, and mostly in handlers rather than eaters. Aimed patch testing in Compositae-allergic patients found positive lettuce reactions in 11% and 22% across two Danish studies, with most cases non-occupational and partly attributable to cross-reactivity 26Reference 26ReviewLettuce contact allergy — reviewView study →. Sesquiterpene lactones are the recognised Compositae hapten class, and systemic allergic dermatitis after ingestion is proven most convincingly for strong allergens such as costunolide in bay leaves and less so for the weak allergens of lettuce 27Reference 27ReviewSystemic allergic dermatitis caused by sesquiterpene lactones — reviewView study → — so lettuce lactones, lactucin included, are best described as weak sensitisers.
The screening trap matters here. The standard sesquiterpene lactone (SL) mix patch reagent contains only three haptens — alantolactone, costunolide and dehydrocostus lactone 25Reference 25Clinical trialSensitization and cross-reaction patterns in Danish Compositae-allergic patients — clinical studyView study → — and lactucin is not one of them. The lettuce-allergy review is explicit that SL mix is a poor screening agent for lettuce contact allergy, with positive reactions significantly more common in non-occupationally sensitised patients, and recommends patch testing with freshly cut lettuce stem supplemented by Compositae mix instead, because lettuce allergens degrade easily 26Reference 26ReviewLettuce contact allergy — reviewView study →. A negative SL-mix patch test does not exclude sensitivity to lettuce or to lactucin. Prick-to-prick testing is also advised, since contact urticaria and protein contact dermatitis can present as dermatitis 26Reference 26ReviewLettuce contact allergy — reviewView study →.
I could not locate a study attributing lettuce patch-test positivity to lactucin as an individual hapten; the class attribution is solid, the molecule-level attribution is not.
- Ordinary dietary exposure is well tolerated. Lactucin is a normal constituent of lettuce, endive, escarole and chicory root; human volunteers show only routine metabolite excretion after a salad 4Reference 4Clinical trialHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteersView study →.
- Additive sedation is the predictable interaction. Benzodiazepine-site activity means CNS depressants, alcohol and sedating medications should be treated as additive — inferred from mechanism, never tested in humans 1,
2Reference 1AnimalAnalgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice — animal in vivoView study →Reference 2AnimalEffectiveness of the sleep enhancement by green romaine lettuce (Lactuca sativa) in a rodent model — animal in vivoView study → . - Concentrated wild-lettuce preparations have their own overdose record. Case reports document toxicity and abuse of Lactuca virosa, with agitation and CNS effects; this is a plant-level signal, not a lactucin one 28,
29Reference 28Case reportWild lettuce (Lactuca virosa) toxicity — case reportView study →Reference 29Case reportAbuse of Lactuca virosa — case reportView study → . - Asteraceae contact allergy — and the SL-mix test will not rule it out. The standard SL mix contains alantolactone, costunolide and dehydrocostus lactone only; a negative result does not exclude lettuce or lactucin sensitivity 25,
26Reference 25Clinical trialSensitization and cross-reaction patterns in Danish Compositae-allergic patients — clinical studyView study →Reference 26ReviewLettuce contact allergy — reviewView study → . - No isolate toxicology exists. No LD₅₀, repeat-dose, genotoxicity, reproductive or CYP/transporter data for pure lactucin. The low rating rests on dietary history, not on testing.
Dosage
There is no established human dose for lactucin, and none is offered. No clinical trial has administered it, no oral bioavailability figure exists, and the gut microbiota chemically alters the molecule before absorption 4Reference 4Clinical trialHuman gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteersView study →. Everything below is a research figure reported in the cited studies, listed so the numbers here can be read in context.
| Context | Model | Figure studied |
|---|---|---|
| Analgesia (hot-plate, tail-flick) | mouse, isolated lactucin | 15 and 30 mg/kg — comparable to ibuprofen 30–60 mg/kg 1Reference 1AnimalAnalgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice — animal in vivoView study → |
| Sedation (spontaneous locomotor activity) | mouse, isolated lactucin | same dosing series as above 1Reference 1AnimalAnalgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice — animal in vivoView study → |
| Sleep promotion | mouse, green romaine lettuce extract | 100 mg/kg oral extract (containing ~1,072 µg/g lactucin) 2Reference 2AnimalEffectiveness of the sleep enhancement by green romaine lettuce (Lactuca sativa) in a rodent model — animal in vivoView study → |
| Anti-neuroinflammation | cultured cells | IC₅₀ 1.82 ± 0.27 µM 6Reference 6In vitroGuaianolide sesquiterpene lactones from Cichorium glandulosum and their anti-neuroinflammation activities — in vitroView study → |
| GABA-A benzodiazepine site | radioligand binding | 80.7% [³H]-flumazenil displacement (concentration not stated) 2Reference 2AnimalEffectiveness of the sleep enhancement by green romaine lettuce (Lactuca sativa) in a rodent model — animal in vivoView study → |
Human exposure, for scale. The realistic routes are dietary — bitter lettuces, endive, escarole, chicory root and roasted chicory — plus traditional wild-lettuce tea, tincture or lactucarium, none of which is standardised for lactucin content. Because the plant stores lactucin as conjugates whose hydrolysis depends on handling 3Reference 3In vitroMetabolite profiling of sesquiterpene lactones from Lactuca species: major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives — in vitroView study →, and because chicory lactucin content is now a deliberate breeding variable 5Reference 5In vitroLactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.) — in vitroView study →, two nominally identical preparations can differ substantially.
These are doses studied in research and are not a personal recommendation.
References
- Wesołowska A, Nikiforuk A, Michalska K, Kisiel W, Chojnacka-Wójcik E (2006). Analgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice — animal in vivo. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/16621374/
- Kim HW, Suh HJ, Choi HS, Hong KB, Jo K (2019). Effectiveness of the sleep enhancement by green romaine lettuce (Lactuca sativa) in a rodent model — animal in vivo. Biological & Pharmaceutical Bulletin. https://pubmed.ncbi.nlm.nih.gov/31582660/
- Sessa RA, Bennett MH, Lewis MJ, Mansfield JW, Beale MH (2000). Metabolite profiling of sesquiterpene lactones from Lactuca species: major latex components are novel oxalate and sulfate conjugates of lactucin and its derivatives — in vitro. Journal of Biological Chemistry. https://pubmed.ncbi.nlm.nih.gov/10858433/
- García CJ, Beltrán D, Tomás-Barberán FA (2020). Human gut microbiota metabolism of dietary sesquiterpene lactones: untargeted metabolomics study of lactucopicrin and lactucin conversion in vitro and in vivo — human volunteers. Molecular Nutrition & Food Research. https://pubmed.ncbi.nlm.nih.gov/32970341/
- Cankar K, Hakkert JC, Sevenier R, et al. (2023). Lactucin synthase inactivation boosts the accumulation of anti-inflammatory 8-deoxylactucin and its derivatives in chicory (Cichorium intybus L.) — in vitro. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/37036799/
- Wei Z, Turak A, Li B, Aisa HA (2024). Guaianolide sesquiterpene lactones from Cichorium glandulosum and their anti-neuroinflammation activities — in vitro. Phytochemistry. https://pubmed.ncbi.nlm.nih.gov/39032793/
- Qin D, Han C, Gao Y, Li H, Zhu L (2024). Lactucin reverses liver fibrosis by inhibiting TGF-β1/STAT3 signaling pathway and regulating short-chain fatty acids metabolism — animal in vivo. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/39164375/
- Zhu L, Lv B, Gao Y, Qin D (2025). Lactucin alleviates liver fibrosis by regulating the TLR4-MyD88-MAPK/NF-κB signaling pathway through intestinal flora — animal in vivo. Archives of Biochemistry and Biophysics. https://pubmed.ncbi.nlm.nih.gov/39952453/
- Zhong Y, Yan J, Lei Y, et al. (2025). Lactucin and lactucopicrin ameliorate obesity in high-fat diet fed mice by promoting white adipose tissue browning through activation of the AMPK/SIRT1/PGC-1α pathway — animal in vivo. Journal of Nutritional Biochemistry. https://pubmed.ncbi.nlm.nih.gov/39909319/
- Wang X, Liu M, Cai GH, et al. (2020). A potential nutraceutical candidate lactucin inhibits adipogenesis through downregulation of JAK2/STAT3 signaling pathway-mediated mitotic clonal expansion — in vitro. Cells. https://pubmed.ncbi.nlm.nih.gov/32023857/
- Zheng H, Kang K, Zhang Y, Lin L, Gan L (2025). Lactucin enhances glucose uptake and glycolysis in C2C12 myotubes by activating AMPK signaling pathway — in vitro. Natural Product Research. https://pubmed.ncbi.nlm.nih.gov/41025855/
- Aibaidula Y, Aimaiti M, Tan H, Chen B, Yang J, Ma X (2022). Lactucin & lactucopicrin ameliorates FFA-induced steatosis in HepG2 cells via modulating lipid metabolism — in vitro. Journal of Pharmacological Sciences. https://pubmed.ncbi.nlm.nih.gov/36055749/
- Lei Y, Ma XL, Liu T, et al. (2024). Lactucin ameliorates FFA-induced steatosis in HepG2 cells by modulating mitochondrial homeostasis through the SIRT1/PGC-1α signaling axis — in vitro. Heliyon. https://pubmed.ncbi.nlm.nih.gov/39524853/
- Ma X, Aibaidula Y, Zhang C, et al. (2025). Lactucin alleviates lipid accumulation via AMPK-mediated autophagy and fatty acid β-oxidation in FFA-induced HepG2 cells — in vitro. Journal of Pharmacological Sciences. https://pubmed.ncbi.nlm.nih.gov/40866016/
- Wei D, Wang PL, Jiang J (2026). Lactucin inhibits growth and induces apoptosis in gastric cancer cells by targeting MAPK signaling — animal in vivo (xenograft). Folia Histochemica et Cytobiologica. https://pubmed.ncbi.nlm.nih.gov/42138553/
- Imam KMSU, Tian Y, Xin F, Xie Y, Wen B (2022). Lactucin, a bitter sesquiterpene from Cichorium intybus, inhibits cancer cell proliferation by downregulating the MAPK and central carbon metabolism pathway — in vitro. Molecules. https://pubmed.ncbi.nlm.nih.gov/36364182/
- Jang JH, Park CY, Sung EG, et al. (2021). Lactucin induces apoptosis through reactive oxygen species-mediated BCL-2 and CFLAR(L) downregulation in Caki-1 cells — in vitro. Genes & Genomics. https://pubmed.ncbi.nlm.nih.gov/34302634/
- Bischoff TA, Kelley CJ, Karchesy Y, Laurantos M, Nguyen-Dinh P, Arefi AG (2004). Antimalarial activity of lactucin and lactucopicrin: sesquiterpene lactones isolated from Cichorium intybus L. — in vitro. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/15507374/
- Trojanowska A (2005). Lettuce (Lactuca sp.) as a medicinal plant in Polish publications of the 19th century — historical review. Kwartalnik Historii Nauki i Techniki. https://pubmed.ncbi.nlm.nih.gov/17153150/
- Ahn Y, Lee HH, Kim BH, et al. (2023). Heukharang lettuce (Lactuca sativa L.) leaf extract displays sleep-promoting effects through GABA-A receptor — animal in vivo. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/37149068/
- Lee M, Park J, Cho W, et al. (2024). Lactuca sativa L. extract enhances sleep duration through upregulation of adenosine A1 receptor and GABA-A receptor subunits in pentobarbital-injected mice — animal in vivo. Journal of Medicinal Food. https://pubmed.ncbi.nlm.nih.gov/38603571/
- Kim HD, Hong KB, Noh DO, Suh HJ (2017). Sleep-inducing effect of lettuce (Lactuca sativa) varieties on pentobarbital-induced sleep — animal in vivo. Food Science and Biotechnology. https://pubmed.ncbi.nlm.nih.gov/30263607/
- Rollinger JM, Mocka P, Zidorn C, Ellmerer EP, Langer T, Stuppner H (2005). Application of the in combo screening approach for the discovery of non-alkaloid acetylcholinesterase inhibitors from Cichorium intybus — in vitro. Current Drug Discovery Technologies. https://pubmed.ncbi.nlm.nih.gov/16472227/
- Jaśkiewicz A, Budryn G, Carmena-Bargueño M, Pérez-Sánchez H (2022). Evaluation of activity of sesquiterpene lactones and chicory extracts as acetylcholinesterase inhibitors assayed in calorimetric and docking simulation studies — in vitro. Nutrients. https://pubmed.ncbi.nlm.nih.gov/36079888/
- Paulsen E, Andersen KE, Hausen BM (2001). Sensitization and cross-reaction patterns in Danish Compositae-allergic patients — clinical study. Contact Dermatitis. https://pubmed.ncbi.nlm.nih.gov/11683829/
- Paulsen E, Andersen KE (2016). Lettuce contact allergy — review. Contact Dermatitis. https://pubmed.ncbi.nlm.nih.gov/26289653/
- Paulsen E (2017). Systemic allergic dermatitis caused by sesquiterpene lactones — review. Contact Dermatitis. https://pubmed.ncbi.nlm.nih.gov/27568784/
- Besharat S, Besharat M, Jabbari A (2009). Wild lettuce (Lactuca virosa) toxicity — case report. BMJ Case Reports. https://pubmed.ncbi.nlm.nih.gov/21686920/
- Spadari M, Pommier P, Canioni D, Arditti J, David JM, Valli M (2003). Abuse of Lactuca virosa — case report. Presse Médicale. https://pubmed.ncbi.nlm.nih.gov/12762295/
- Bogdanović M, Cankar K, Dragićević M, et al. (2020). Silencing of germacrene A synthase genes reduces guaianolide oxalate content in Cichorium intybus L. — in vitro. GM Crops & Food. https://pubmed.ncbi.nlm.nih.gov/31668117/
- Ruggieri F, Hance P, Gioia B, et al. (2023). A three-step process to isolate large quantities of bioactive sesquiterpene lactones from Cichorium intybus L. roots and semisynthesis of chicory STL standards — laboratory method. Pharmaceuticals. https://pubmed.ncbi.nlm.nih.gov/37242554/
- Schenck G, Loth H, Reubert W (1961). Research on the preparation of lactucin and lactucopicrin from Lactuca virosa plants (15: on the enzymatic and non-enzymatic oxidation of therapeutically active plant substances) — laboratory method. Archiv der Pharmazie. https://pubmed.ncbi.nlm.nih.gov/13747469/
- Schenck G, Huke M, Naumann T (1964). Studies on the photochemical transformation of lactucin — laboratory study. Archiv der Pharmazie. https://pubmed.ncbi.nlm.nih.gov/5212814/
- Weng H, He L, Liu X, et al. (2021). Natural lactucopicrin alleviates importin-α3-mediated NF-κB activation in inflamed endothelial cells and improves sepsis in mice — animal in vivo. Biochemical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/33684389/
- Taechowisan T, Chuen-Im T, Phutdhawong WS (2024). Apoptotic potential and molecular docking of 3,4-dihydro-lactucin, a compound with anticancer properties derived from Microbispora rosea AL22 — in vitro. Anticancer Research. https://pubmed.ncbi.nlm.nih.gov/38423670/
- Kisiel W, Michalska K (2003). Root constituents of Cichorium pumilum and rearrangements of some lactucin-like guaianolides — in vitro. Zeitschrift für Naturforschung C. https://pubmed.ncbi.nlm.nih.gov/14713151/
- Michalska K, Szneler E, Kisiel W (2011). Complete NMR spectral assignments of two lactucin-type sesquiterpene lactone glycosides from Picris conyzoides — laboratory study. Magnetic Resonance in Chemistry. https://pubmed.ncbi.nlm.nih.gov/22002327/
- Testone G, Mele G, Di Giacomo E, et al. (2016). Insights into the sesquiterpenoid pathway by metabolic profiling and de novo transcriptome assembly of stem-chicory (Cichorium intybus cultigroup “Catalogna”) — in vitro. Frontiers in Plant Science. https://pubmed.ncbi.nlm.nih.gov/27877190/
